Benzinga | Feb 25, 2021 04:58PM EST

Dicerna Pharmaceuticals Q4 EPS $(0.49) Misses $(0.03) Estimate, Sales $40.96M Miss $67.25M Estimate

Dicerna Pharmaceuticals (NASDAQ:DRNA) reported quarterly losses of $(0.49) per share which missed the analyst consensus estimate of $(0.03) by 1533.33 percent. This is a 15.52 percent increase over losses of $(0.58) per share from the same period last year. The company reported quarterly sales of $40.96 million which missed the analyst consensus estimate of $67.25 million by 39.10 percent. This is a 478.47 percent increase over sales of $7.08 million the same period last year.